Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Hong Kong Disease – Management Updates

Similar presentations


Presentation on theme: "The Hong Kong Disease – Management Updates"— Presentation transcript:

1 The Hong Kong Disease – Management Updates
JHSGR 17/5/2008 The Hong Kong Disease – Management Updates Dr. YF Yeung Department of Surgery Prince of Wales Hospital

2 The Hong Kong Disease SARS

3 The Hong Kong Disease Recurrent Pyogenic Cholangitis (RPC)
Oriental cholangitis Oriental cholangiohepatitis Intrahepatic pigmented calculus disease

4 Recurrent Pyogenic Cholangitis
Cook in 1954 Repeated primary biliary infection Pus-forming bacteria Multiple stones and strictures in the biliary tree Pathogenesis not well understood nowadays Calcium bilirubinate stones within extra- and intraheptic biliary ducts

5 Aetiology ? Oriental diet ? Poor environmental hygiene
Low saturated fat: biliary stasis Low protein diet: increased formation of calcium bilirubinate stones ? Poor environmental hygiene Recurrent enteric infection and portal bacteraemia ? Clonorchis sinensis and Ascaris lumbricoids

6 Epidemiology Predominantly lower socio-economic class and rural areas
Male = Female Peak age incidence: 3rd to 4th decades Overall incidence is decreasing in East Asia HK experience : 30 patients / year : 22.8 patients / year Lo et al. HKMJ 1997 Increasing incidence in the West due to Asian immigrants

7 Why intervention important?
Complications of RPC Recurrent cholangitis Liver abscess Parenchyma atrophy Biliary cirrhosis Cholangiocarcinoma

8 Imaging Features ERCP Truncated tree sign Ductal ectasia
Abrupt tapering Arrow head appearance

9 Imaging Features Percutaneous Transhepatic Cholangiography
Severe stricture Dilated ducts Multiple filling defects

10 Imaging Features MRCP Dilated ducts Strictures Filling defects

11 Imaging Features CT Hepatolithiasis Parenchymal atrophy
Obliterated portal vein

12 Management - Multidisciplinary
Acute episode Control of biliary sepsis Drainage +/- extraction of stones ERCP PTC Definitive treatment Correction of anatomic abnormalities/ sources of chronic infections

13 Definitive Management
Surgical ECBD Liver Resection Drainage Procedure Endoscopic Percutaneous Transhepatic Cholangioscopic Lithotripsy (PTCL) “mother-baby” endoscope system

14 Hepatectomy Indications Stones localized in unilateral lobe
Bile duct stricture Atrophy of affected segments/ lobe Suspected cholangiocarcinoma Failed / recurrent disease after non-operative treatment

15 Hepatectomy Series n Mortality Morbidity Stone Clearance Cholangio-CA
FU (mth) Recur-rence Chen 2004 103 2% 28% 98% 10% 56 7.8% Cheung 2005 52 3.8% 33.3% 58 13.3% (5 yrs) Uchiyama 2007 38 0% 23.7% 100% 7.9% 108 13.9% Lee 2007 123 1.6% 92.7% 2.4% 40.3 5.7%

16 Drainage Procedure Principle Indications Eliminate biliary stasis
Newly formed stones can pass unimpeded into the bowel Indications Extrahepatic ductal stones Extrahepatic biliary stricture Grossly dilated common duct with problem of bile stasis

17 Drainage Procedure Choledochoduodenostomy (CD)
Sump syndrome Ascending cholangitis High risk of stasis Hepaticojejunostomy (HJ) Hinder post-operative choledochoscopic removal of residual stones Hepaticocutaneous jejunostomy with a stoma for easy access Possible complications: fistula, infection, parastomal hernia, early stoma closure Sphincteroplasty Parilla P et al. BJS 1991 Rat P et al. Hepatogastroenterology 1993 Huang et al. Am J Gastroenterol 2003

18 Is Drainage Procedure a MUST after hepatectomy?

19 Intra-op bleeding OT time Residual stone Post-op cholangitis
World J Gastroenterololgy 2006 Intra-op bleeding OT time Residual stone Post-op cholangitis Liver resection(76) 500ml 282min 18.4% 22% HJ ECBD (47) 300ml 226min 23.4% 27% 314 patients Liver resection (85) 189min 21.2% 8.2% T-tube ECBD (106) 150ml 166min 34% 35.7%

20 Concluded indications for HJ
World J Gastroenterololgy 2006 Median FU 7.6 years (2-12) Concluded indications for HJ Hepatolithiasis complicated with extrahepatic ducts or its second branches stricture Hepatolithiasis with congenital bile duct dilatation in which the dilated bile duct should be resected Dysfunction of the papilla of Vater

21 Percutaneous Transhepatic Cholangioscopic Lithotripsy (PTCL)
Indications Stones distributed in multiple segments Previous biliary surgery Poor surgical risk Refuse surgery

22 PTCL Causes of incomplete stone clearance
Biliary stricture Bile duct angulation Muddy stones with sludge Peripheral stone distribution Biliary stricture is the major determinant for recurrence

23 PTCL Series N Mortality Morbidity Stone clearance Recurrence
Mean FU (mths) Huang 2003 245 0.8 1.6% 85.3% 63.2% 209 Cheung 79 7.6% 76.8% 30% 37.3 Chen 2005 74 3% 82% 59% 121

24 J Am Coll Surg 1999 Morbidity Mortality Stone clearance 5 yr recurrence 10 yr recurrence Hepatec -tomy(26) 38.5% 3.8% 96.2% 5.6% 16.0% 54 patients PTCL (28) 21.4% 3.6% 96.4% 31.5% 54.3%

25 Our Experience on Hepatectomy for RPC
Series N Mortality Morbidity Stone Clearance Cholangio-CA FU (mth) Recur rence PWH 66 36.4% 93.9% 6.1% 42.7 12.9% Chen 2004 103 2% 28% 98% 10% 56 7.8% Cheung 2005 52 3.8% 33.3% 58 13.3% (5 yrs) Uchiyama 2007 38 0% 23.7% 100% 7.9% 108 13.9% Lee 2007 123 1.6% 92.7% 2.4% 40.3 5.7%

26 Conclusion RPC is not “dead” in Hong Kong
Health care burden in HK for the recurrent nature of the disease Management should be of multidisciplinary approach and tailored to individual patient Hepatectomy is safe and effective


Download ppt "The Hong Kong Disease – Management Updates"

Similar presentations


Ads by Google